Aztreonam
Monobactam
limited to aerobic Gr(-) organisms
Resistant to beta-lactamases by some organisms
Klebsiella, Pseudomonas, Serratia
An inhibitor of cell wall synthesis binding to PBP3
No activity against gram (+) and anaerobes
Synergistic with aminoglycosides
No cross-allergenicity with penicillin
renal tubular secretion
Aztreonam:
Eliminated via ___
prolonged
Aztreonam:
Half-life is ___ in renal failure
Carbapenems
Low susceptibility to beta-lactamases
Resistant to most β –lactamases, ESBL (extended-spectrum BL)
Wide activity against Gram(+) cocci, Gram (-) rods, Anaerobes
Pseudomonal infections
Drug of choice for Enterobacter
renal (kidney)
Carbapenems:
Excretion
Imipenem
Carbapenems:
Rapidly inactivated by renal dehydropeptidases I
Partial cross-allergenicity with penicillins
Cilastatin
Inhibitor of the enzyme
Increases the half-life
Inhibits formation of nephrotoxic metabolites
Carbapenems: Imipenem
imipenem is combined with ___ which inhibits dehydropeptidase enzymes in renal tubules that inhibit imipenem
Meropenem
cot metabolized by renal dehydropeptidases
Less likely to cause seizure
Ertapenem
Carbapenems:
Less active against pseudomonas
IM injection causes pain and irritation
Clavulanic acid, Sulbactam, Tazobactam
Used in fixed combination with certain hydrolyzable penicillins
Plasmid-encoded beta-lactamases
Vancomycin
Inhibitors of Cell Wall Synthesis:
Bactericidal Against Gram-positive cocci and anaerobes
Isolated from the bacterium Amycolatopsis orientalis
Inhibits transglycosylation
drug of choice for methicillin-resistant S. aureus (MRSA)
D-Ala-D-Ala terminal
Inhibitors of Cell Wall Synthesis: Vancomycin
Binds to the ___ of the nascent peptidoglycan pentapeptide side chain
Red Man Syndrome
Inhibitors of Cell Wall Synthesis: Vancomycin
Rapid IV infusion may cause diffuse blushing a syndrome known as ___
Teicoplanin
Inhibitors of Cell Wall Synthesis: Vancomycin
Similar drug
Fosfomycin
Inhibitors of Cell Wall Synthesis:
Prevents the formation of N-acetylmuramic acid which is essential in peptidoglycan chain formation
Synergistic with beta-lactam and quinolones in specific infections
decreased intracellular accumulation of the drug
Inhibitors of Cell Wall Synthesis: Fosfomycin
Resistance occurs via ___
Antimetabolite inhibitor of cytosolic enolpyruvate transferase
Inhibitors of Cell Wall Synthesis: Fosfomycin
Inhibits addition of phosphoenolpyruvate to UDP-N-acetylglucosamine
kidney with urinary levels exceeding the MICs for many urinary tract pathogens
Inhibitors of Cell Wall Synthesis: Fosfomycin
Excretion
uncomplicated cystitis (UTI)
Inhibitors of Cell Wall Synthesis: Fosfomycin
Clinical Use
fluoroquinolones
Inhibitors of Cell Wall Synthesis: Fosfomycin
Drug is less effective than the 7-day course of treatment with ___
Bacitracin
Inhibitors of Cell Wall Synthesis:
Peptide antibiotic
Interferes with a late stage in cell wall synthesis in gram (+) organisms
Topical only
highly nephrotoxic when administered systemically
Tracy strain of Bacillus subtilis
lipid carrier that transfers peptidoglycan subunits
Inhibitors of Cell Wall Synthesis: Bacitracin
Inhibits cell wall formation by interfering with the ___ to the growing cell wall
Cycloserine
Inhibitors of Cell Wall Synthesis:
Antimetabolite
Used only in TB caused by organisms resistant to first-line antituberculous drugs
Produced by Streptomyces orchidaceous
D-alanine (tetrapeptide cross linker)
Inhibitors of Cell Wall Synthesis: Cycloserine
Inhibits incorporation of ___ into peptidoglycan pentapeptide by inhibiting alanine racemase, which converts l-alanine to d-alanine, and d-alanyl-d-alanine ligase
Daptomycin
Inhibitors of Cell Wall Synthesis:
Lipopeptide
vancomycin-resistant strains of enterococci and S aureus (VRE, VRSA)
Fermentation product of Streptomyces roseosporus
myopathy
Depolarization
Inhibitors of Cell Wall Synthesis: Daptomycin
___ of the cell membrane with potassium efflux and rapid cell death
Pulmonary surfactant
Inhibitors of Cell Wall Synthesis: Daptomycin
___ antagonizes daptomycin, and it should not be used to treat pneumonia